1998
DOI: 10.1006/jmbi.1998.1907
|View full text |Cite
|
Sign up to set email alerts
|

The role of structure in antibody cross-reactivity between peptides and folded proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
60
1

Year Published

1998
1998
2019
2019

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 87 publications
(64 citation statements)
references
References 95 publications
3
60
1
Order By: Relevance
“…Importantly, the binding to the LACDE sequence is also inhibited by the purified PDC mitochondrial antigen, demonstrating that the cross-reactive microbial/self recognition targets the naturally occurring autoantigen. 25,32 These findings are in sharp contrast to those obtained for ECOLI PDC-E2 231-245 , which has proved to be a poor inhibitor of anti-human PDC-E2 212-226 reactivity.…”
Section: Discussioncontrasting
confidence: 60%
“…Importantly, the binding to the LACDE sequence is also inhibited by the purified PDC mitochondrial antigen, demonstrating that the cross-reactive microbial/self recognition targets the naturally occurring autoantigen. 25,32 These findings are in sharp contrast to those obtained for ECOLI PDC-E2 231-245 , which has proved to be a poor inhibitor of anti-human PDC-E2 212-226 reactivity.…”
Section: Discussioncontrasting
confidence: 60%
“…Because of its length and extreme cost to produce, Santa Cruz does not offer a blocking peptide for the R-101 antibody, and it was for this reason that we tried the synthetic peptide antibodies that both have blocking peptides available as shown in Figures 4L and 4M (for the N-terminal antibody). It is not surprising that the R-101 antibody gave better overall results compared with the shorter synthetic peptide antibodies, because such an outcome can happen and is not unique to AQP 7 (Craig et al 1998). What is surprising is that neither of the synthetic peptide antibodies showed lateral or basal reactions characteristic of the R-101 antibody, and the C-terminal antibody was completely negative for AQP 7 in epididymis.…”
Section: Discussionmentioning
confidence: 99%
“…Molecular mimicry to the cognate antigen seems to be required for inducing a functional, cross-reactive immune response. 1 In several studies this functional molecular mimicry has been achieved by a trial-and-error approach, 2 -7 by combinatorial chemistry display techniques 8,9 or by structure-based design. 10 -12 Similar to approaches in structure-based drug design, crystal or solution structures of peptide-antibody complexes are often used to optimize the complementarity between a peptide and a functional antibody, which should thus lead to higher binding affinity.…”
mentioning
confidence: 99%